The sale of several prime urban sites helped the city hit a record high of HK$40 billion in land income as of last month, but it’s not enough to cover gap created by major increases to recurrent ... ( read original story ...)
Pandemic’s dark clouds still cast a shadow over Hong Kong’s economy
Financial Secretary Paul Chan Mo-po this week celebrated encouraging GDP data, predicting that Hong Kong's economy was heading for 6.5 per cent growth this year after huge contractions in the past two ... ( read original story ...)
Airdoc stumbles with Hong Kong IPO
Beijing Airdoc Technology Co. Ltd. raised HK$1.67 billion (US$214.8 million) with its IPO on the Hong Kong Exchange (HKEX) on Nov. 5, falling below its expectations of a $500 million raise. Share ... ( read original story ...)
Clover raises $260M in Hong Kong IPO
Sichuan Clover Biopharmaceuticals Inc. raised HK$2.03 billion (US$260.17 million) in its Hong Kong Stock Exchange debut. Shares closed at HK$12.98 (US$1.67) on Nov. 5 after trading as high as HK$13.56 ... ( read original story ...)
Clover Biopharmaceuticals Shares Fall on Hong Kong Debut
Shares of Chinese Covid-19 vaccine developer Clover Biopharmaceuticals Ltd. fell more than 10% on its Hong Kong debut Friday before rebounding after the initial public offering (IPO) raised $240 ... ( read original story ...)
Chinese COVID vaccine developer Clover raised US$240 million net proceeds in Hong Kong IPO
Chinese COVID-19 vaccine developer Clover Biopharmaceuticals said on Thursday it raised US$240 million in net proceeds in initial public offering (IPO) of shares in Hong Kong.Based on the offer price ... ( read original story ...)
Hong Kong Markets Watchdog Says Sees No Systemic Risk to City From China Property Turmoil
Hong Kong's Securities and Futures Commission has looked very closely at financial institutions in the city's exposure to China's troubled property sector and has not seen any systemic risks for the ... ( read original story ...)
China’s COVID-19 vaccine developer Clover raises $240m in HK IPO
China's COVID-19 vaccine developer Clover Biopharmaceuticals said on Thursday it raised $240 million in net proceeds in an IPO in Hong Kong. ( read original story ...)
HSBC Requests All of Its Hong Kong Staff to Get Vaccinated
HSBC Holdings Plc asked all of its Hong Kong staff to get vaccinated against the Covid virus after city authorities issued a new circular to push for higher inoculation rates. ( read original story ...)
Chinese COVID vaccine developer Clover raised $240 million net proceeds in Hong Kong IPO
Chinese COVID-19 vaccine developer Clover Biopharmaceuticals said on Thursday it raised $240 million in net proceeds in initial public offering (IPO) of shares in Hong Kong. Based on the offer price ... ( read original story ...)
Hong Kong, China, Thailand and UAE explore new uses of ‘mBridge’ digital currency project, including securities settlement
The mBridge digital currency project is looking to expand its use to capital market transactions, which could cut the settlement time to a few seconds. ( read original story ...)
HSBC invests $2b to be a ‘digital first’ bank
Part of that investment means partnering with more fintechs to create digital banking products. HSBC is investing $2b to turn into a ‘digital-first bank’ according to the bank’s chief executive of ... ( read original story ...)
Website and Email Alert – Fraudulent website and phishing emails related to Hang Seng Bank, Limited
The Hong Kong Monetary Authority (HKMA) wishes to alert members of the public to a press release issued by Hang Seng Bank, Limited relating to a fraudulent website and phishing emails, which has been ... ( read original story ...)
HSBC Asset Management hires new regional CEO for Asia Pacific and Hong Kong
HSBC Asset Management has hired Daisy Ho from Fidelity International as its new regional chief executive officer for Asia Pacific and Hong Kong. She succeeds Pedro Bastos, who has been appointed to a ... ( read original story ...)